Vantive Us Hlthcare Drug Patent Portfolio

Vantive Us Hlthcare owns 1 orange book drug protected by 2 US patents Given below is the list of Vantive Us Hlthcare's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6248726 Method of peritoneal dialysis using glucose polymer solutions 19 Jun, 2018 Expired
US6077836 Peritoneal dialysis and compositions for use therein 20 Jun, 2017 Expired


Vantive Us Hlthcare's Drug Patent Litigations

Vantive Us Hlthcare's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jan 01, 1, against patent number US6077836. The petitioner , challenged the validity of this patent, with MILNER as the respondent. Click below to track the latest information on how companies are challenging Vantive Us Hlthcare's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US6248726 May, 1995 Decision
(28 Aug, 2000)
ALSOP et al
US6077836 January, 1 Decision
(14 Sep, 1999)
MILNER


Vantive Us Hlthcare's Family Patents


Family Patents



Vantive Us Hlthcare Drug List

Given below is the complete list of Vantive Us Hlthcare's drugs and the patents protecting them.


1. Extraneal

Extraneal is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6248726 Method of peritoneal dialysis using glucose polymer solutions 19 Jun, 2018
(6 years ago)
Expired
US6077836 Peritoneal dialysis and compositions for use therein 20 Jun, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Extraneal's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List